ZERIA PHARMCEUTICAL CO., LTD.
4559 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋小舟町１０番１１号
- Website:
- https://www.zeria.co.jp/english/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Zeria Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical company dedicated to the research, development, and manufacturing of innovative healthcare solutions. With a strong commitment to enhancing patient well-being, Zeria focuses on areas such as prescription drugs, over-the-counter medications, and specialty pharmaceuticals. The company is known for its robust research and development pipeline, which is continually updated to reflect advancements in medical science. Zeria also emphasizes transparency and shareholder value, as evidenced by its recent communications regarding financial results and executive leadership changes. Through its commitment to quality and innovation, Zeria Pharmaceutical aims to make significant contributions to the global healthcare landscape.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-03 07:19 |
Inside Information Statement
臨時報告書
|
Japanese | 23.2 KB | |
| 2025-06-26 03:01 |
Internal Control over Financial Reporting
内部統制報告書－第71期(2024/04/01－2025/03/31)
|
Japanese | 24.9 KB | |
| 2025-06-26 03:00 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2025-06-26 03:00 |
Annual Report
有価証券報告書－第71期(2024/04/01－2025/03/31)
|
Japanese | 1.5 MB | |
| 2024-11-08 02:01 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2024-11-08 02:00 |
Interim Report
半期報告書－第71期(2024/04/01－2025/03/31)
|
Japanese | 204.2 KB | |
| 2024-07-03 03:44 |
Inside Information Statement
臨時報告書
|
Japanese | 23.8 KB | |
| 2024-06-27 07:11 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2024-06-27 07:09 |
Internal Control over Financial Reporting
内部統制報告書－第70期(2023/04/01－2024/03/31)
|
Japanese | 23.8 KB | |
| 2024-06-27 07:07 |
Annual Report
有価証券報告書－第70期(2023/04/01－2024/03/31)
|
Japanese | 1.2 MB | |
| 2024-02-05 06:04 |
Quarterly Report
四半期報告書－第70期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 168.4 KB | |
| 2024-02-05 06:04 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
| ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
|
Astellas Pharma Inc. | Japan | 4503 | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD |